TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
AXSM

Axsome Therapeutics Inc

Healthcare · Biotechnology

214.30$ +1.1% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Axsome Therapeutics Inc (AXSM): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/02/2026.

Next report 11/02/2026
Last report 08/10/2026
Earnings surprise by quarter (%)
Q3 23 · -10.9 % 23 Q4 23 · -77.8 % 23 Q1 24 · -18.0 % 24 Q2 24 · -25.6 % 24 Q3 24 · 4.8 % 24 Q4 24 · -53.6 % 24 Q1 25 · 9.6 % 25 Q2 25 · 11.0 % 25 Q3 25 · -4.4 % 25 Q4 25 · 22.8 % 25 Q1 26 · -46.5 % 26 Q2 26 · 0.0 % 26

EPS estimate beaten

Full history 17 of 43 quarters (40%)
Last 16 quarters 6 of 16 quarters (38%)

Earnings Call Transcripts

Search all transcripts →

  • 05/04/2026 Earnings Call Q1 2026 Open →
  • 02/23/2026 Earnings Call Q4 2025 Open →
  • 11/03/2025 Earnings Call Q3 2025 Open →
  • 08/04/2025 Earnings Call Q2 2025 Open →
  • 05/05/2025 Earnings Call Q1 2025 Open →
  • 02/18/2025 Earnings Call Q4 2024 Open →
  • 11/12/2024 Earnings Call Q3 2024 Open →
  • 08/05/2024 Earnings Call Q2 2024 Open →
  • 05/06/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/10/2026 Axsome Therapeutics, Inc. (AXSM): Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/15/2026 Axsome Therapeutics, Inc. (AXSM): Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?